Guanghui Liang

The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II Study

Wenqun Xing, Lingdi Zhao, Baoxing Liu et al. · Frontiers in Immunology · 2021 · 72 citations · Full text

Medicine, Oncology, Surgery +16

microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer

Peng Li, Wenqun Xing, Jinliang Xu et al. · Stem Cell Research & Therapy · 2019 · 48 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

A phase II, single-centre trial of neoadjuvant toripalimab plus chemotherapy in locally advanced esophageal squamous cell carcinoma

Wenqun Xing, Lingdi Zhao, Xiaomin Fu et al. · Journal of Thoracic Disease · 2020 · 42 citations · Full text

Medicine, Oncology, Pharmacology +17

Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial

Yan Zheng, Guanghui Liang, Dongfeng Yuan et al. · Cancer Communications · 2024 · 41 citations · Full text

Medicine, Oncology, Surgery +14

A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909)

Xianben Liu, Haibo Sun, Jinliang Xu et al. · Annals of Translational Medicine · 2021 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17